Propofol Cardioprotection for Type II Diabetics

Summary

The purpose of this study is to determine if an intravenous anesthetic with antioxidant properties will protect the heart of diabetic patients from injury while undergoing coronary bypass surgery.

Timeline

Start

2005-04

Primary completion

2012-05

Completion

2012-06

Publications

• Ansley DM, Raedschelders K, Choi PT, Wang B, Cook RC, Chen DD. Propofol cardioprotection for on-pump aortocoronary bypass surgery in patients with type 2 diabetes mellitus (PRO-TECT II): a phase 2 randomized-controlled trial. Can J Anaesth. 2016 Apr;63(4):442-53. doi: 10.1007/s12630-015-0580-z. Epub 2015 Dec 31.

Drugs

Indications